Intech Investment Management LLC lifted its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 96.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 115,930 shares of the company's stock after purchasing an additional 56,778 shares during the quarter. Intech Investment Management LLC owned about 0.13% of Tenet Healthcare worth $23,038,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of THC. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the fourth quarter worth approximately $29,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at $35,000. Finally, Westside Investment Management Inc. raised its stake in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock worth $39,000 after buying an additional 96 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.
Analyst Ratings Changes
THC has been the topic of several research reports. Jefferies Financial Group boosted their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a "buy" rating in a research report on Thursday, February 12th. TD Cowen reiterated a "buy" rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Guggenheim cut their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a "buy" rating for the company in a research note on Friday, May 1st. KeyCorp decreased their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating on the stock in a research report on Friday, May 1st. Finally, Truist Financial increased their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $244.16.
Get Our Latest Research Report on THC
Insiders Place Their Bets
In related news, Director Nadja West sold 3,000 shares of the company's stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director directly owned 24,805 shares of the company's stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total value of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares in the company, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 49,517 shares of company stock valued at $11,475,161 over the last ninety days. Corporate insiders own 0.97% of the company's stock.
Tenet Healthcare Stock Performance
Tenet Healthcare stock opened at $173.45 on Friday. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The firm's 50 day simple moving average is $190.50 and its 200-day simple moving average is $202.06. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company has a market cap of $14.94 billion, a P/E ratio of 9.02, a price-to-earnings-growth ratio of 1.19 and a beta of 1.30.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts' consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter last year, the business posted $4.36 EPS. The company's revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts predict that Tenet Healthcare Corporation will post 17.67 EPS for the current year.
Tenet Healthcare Company Profile
(
Free Report)
Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
